semaglutide
5 Reasons Semaglutide Beats Inpatient Surgery
Semaglutide often outperforms inpatient bariatric surgery in safety, cost, and speed of weight loss, and the FDA’s recent proposal targets three major GLP-1 drugs to curb unauthorized compounding. The latest multicenter trial data show clinicians can cut trial-and-error by two-thirds using a simple dosing algorithm, making personalized GLP-1 therapy